New Jersey investigates Amgen's Enbrel activity

01/17/2008 | NYTimes.com · Seattle Times, The

The New Jersey attorney general has asked Amgen to submit documentation on the marketing push and prescription activity for its best-selling psoriasis treatment, Enbrel, following claims of unethical marketing by two former sales representatives. Amgen said it would cooperate with the investigation and said the accusations have no merit.

View Full Article in:

NYTimes.com · Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN